A detailed history of Qube Research & Technologies LTD transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 865,964 shares of MDXG stock, worth $5.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
865,964
Previous 734,933 17.83%
Holding current value
$5.39 Million
Previous $5.66 Million 6.06%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.16 - $8.08 $807,150 - $1.06 Million
131,031 Added 17.83%
865,964 $6 Million
Q1 2024

May 14, 2024

BUY
$7.61 - $8.63 $2.26 Million - $2.57 Million
297,543 Added 68.03%
734,933 $5.66 Million
Q4 2023

Feb 13, 2024

BUY
$5.7 - $9.14 $1.95 Million - $3.13 Million
342,281 Added 359.88%
437,390 $3.84 Million
Q3 2023

Nov 13, 2023

SELL
$6.35 - $8.16 $45,167 - $58,042
-7,113 Reduced 6.96%
95,109 $693,000
Q2 2023

Aug 14, 2023

BUY
$3.14 - $6.61 $109,375 - $230,246
34,833 Added 51.69%
102,222 $675,000
Q1 2023

May 15, 2023

BUY
$2.97 - $4.81 $200,145 - $324,141
67,389 New
67,389 $229,000
Q2 2022

Aug 15, 2022

BUY
$3.17 - $5.0 $103,351 - $163,015
32,603 New
32,603 $113,000
Q1 2022

May 09, 2022

SELL
$4.27 - $6.27 $192,820 - $283,134
-45,157 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$5.7 - $8.48 $257,394 - $382,931
45,157 New
45,157 $273,000
Q2 2021

Aug 13, 2021

SELL
$9.02 - $12.72 $993,679 - $1.4 Million
-110,164 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$8.48 - $11.28 $1.37 Million - $1.83 Million
-162,085 Reduced 59.54%
110,164 $1.14 Million
Q4 2020

Feb 16, 2021

BUY
$5.32 - $10.17 $1.45 Million - $2.77 Million
272,249 New
272,249 $2.47 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $708M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.